¤é¥»ÃïÀ¦b§Ú̪º¤j¥xÆW¦a°Ï¤@ª½½æ±o«Ü¦n¡A¦Ó¥B¦h¦~¨Ó¥¦ªº¨üÅwªïµ{«×¨Ã¨S¦³°§C¡C«Ü¦h¤H³£±q¥¼°±¤î¹L´M§ä¥¿©vªº¤é¥»ÃïÀ¡CÁʶR¨ì°²³f½T¹ê«Ü³Â·Ð¡C§ÚÌ¥u¯à»¡¡A¶V¨Ó¶V¦hªººô¯¸¾P°â¤é¥»ÃïÀ¡A³o¨Ï¨CÓ¤H³£µLªk¹w´úºô¯¸°â½æªº¤é¥»ÃïÀªº¯u¹ê©Ê¡C¦³¨ÇªB¤Í¦^·Q°_¤é¥»ÃïÀªºÁʶR¡A³£¬°¹L¥hªººGµh¸g¾ú¦Ó·P¹Ä¡C§ó¥O¤H·Ð´oªº¬O¡A¦³®É·í±zÁʶR°²³f¨Ã·Q§ä¨ì°Ó®a²z½×®É°Ó®a¥i¯à·|¥H¦UºØ¦U¼Ëªº²z¥Ñ¨Ó¶i¦æ±À²æ¡CÁʶR°²³f·l¥¢¿ú°]¬O¤p¨Æ¡A«ÂI¬O¦Y¤F°²ÃÄ®e©ö¶Ë®`¨Åé¡I

§Ú̪ººô¯¸°ò©ó¡u°ò©ó¸Û«H¡AªA°È¦Ü¤W¡vªºì«h¡Aµ´¹ï½T«O§Ú̵o°eªº¨C¤@Åø¤é¥»ÃïÀ³£¬°¦³®Äªº¥¿©v²£«~¡C§Ú̱N¦b¾ãÓ¹Lµ{¤¤¬°±z´£¨Ñ³Ì¦nªºªA°È¡Aª½¨ì±zº¡·N¬°¤î¡I¦pªG¦b§Ú̪ººô¯¸¤WqÁʪº¤é¥»ÃïÀ¬OµL®Äªº©M°°³yªº¡A§Ṳ́@©w·|´£¨Ñ°h´ÚªA°È¡C§Ú̱N³q¹L«ÈªAª½±µ¸Ñ¨M±zªº¨CÓ°ÝÃD¡A¦Ó¤£·|°jÁשΪý¼¸¤j®a´£¥X°ÝÃD©ÎªÌ¬OºûÅv¡AÅý±z¤£¨«Ås¸ô¡A¤£³Q´ÛÄF¡C
¤U±¡A§Ú̱N¹ï«È¤áªº¤@¨Ç±`¨£°ÝÃDµ¹¥X¤@¨Ç²³æªºµª®×¡C
1.¥¿©v¤é¥»ÃïÀªº»ù®æ¬O¦h¤Ö¡H
«È¤á¸g±`°Ý§ÚÌ¡Gºô»Úºô¸ô¤W¤é¥»ÃïÀ°â½æªº»ù®æ¬°¤°»ò¤£¦P¡H¥¿©v¤é¥»ÃïÀªº»ù®æ¬ù¬°¨CÅø1500¤¸¡Aªi°Ê¤£·|¤Ó¤j¡C¥Ñ©ó§ÚÌ¥²¶·³q¹L®üÃö¨Ã¥²¶·Ãºµ|¡A¦]¦¹±q¾P°â¥¿©vªº¤é¥»ÃïÀ¤¤§Ú̵LªkÀò§Q«Ü¦h¡C¦pªG±z·Qn¥h©ç½æºô¯¸qÁÊ´X¦Ê¤¸¤@Åøªº¤é¥»ÃáA¨º»ò±z¤@©wn¤p¤ß¤£n³QÄF¤F¡I¦bGoogle¼s§i±À°eªººô¯¸¶i¦æÁʶRªº®ÉÔ¡A±z¦P®É¤]»Ýn«O«ùÂÔ·V¡C
§Y¨Ï§ÚÌ¥i¥H³q¹L¿z¿ï¥i«Hªººô¯¸¨ÓÁקK³QÄF¡A¦ý¬O¤]¤£¬O»¡´N¥i¥H§¹¥þ¶R¨ì¯u¥¿ªº¤é¥»ÃïÀ¡C§ÚÌÁÙ»Ýn¦³¤@©wªºÅ²§O¯u°°ªºª¾ÃÑ¡C¤é¥»ÃïÀ¦p¦ó¿ë§O¯u°°¡H
¨CÓ¤H³£«D±`Ãö¤ß³oÓ°ÝÃD¡A¦]¬°ÃĪ«ªº¯u°²Ãö«Y¨ì¨CÓ¤Hªºª÷¿ú©M°·±d¡Cº¥ý¡A§ÚÌ»Ýnª¾¹D¥¿©vªº¤é¥»ÃïÀ²°¤lªº¦rÅ馳¥W¥Y·P¡AÃö©ó³o¤@ÂI§Ṳ́£¦h»¡¡A¤j®a¥un¥J²ÓÆ[¹î´N¥i¥H¬Ý¥X¨Ó¤F¡C
3.¤é¥»ÃïÀªº¥Dn§@¥Î¬O¤°»ò¡H

¤é¥»ÃïÀ¤w³Q¤é¥»ÃĪ«ºÞ²z§½¡]Japan Drug Administration¡^»{¥i¬°¨k©Ê¤Q¤j¦w¥þÃĪ«¤§¤@¡C¤é¥»ÃïÀ¦b¥«³õ§ë©ñ«á¡A¥þ¥@¬É¤w¦³¶W¹L¤@¤d¸Uªº¤H³ßÅw¥¦¡C¥¦¤w¦b¤é¥»AV¦æ·~¤¤¼s¨ü±À±R¡A¨Ã¤w¦¨¬°AV¨kÀu̵L¼ÄªºªkÄ_¡C¦Y¤F¤é¥»ÃïÀ«á¡A³\¦hÅU«È¤]·R¤W¤F³oºØ²£«~¡C¤é¥»ÃïÀªº¥Dn§@¥Î¬OªvÀø¨k©Ê©Ê¥\¯à»Ùê¡A¤£¯à«k°_¡A¶§·õ¡AµÇŦ¤£¨¬¡A¨Åéµê®z©Mºë¤O¤£¨¬¡C¤é¥»ÃïÀ¹ï©Ê¥æ®É®e©ö¯h³Òªº¤H¡A©Ê¥Í¬¡½è¶q§C¤Uªº¤H¡A¥Í´Þ¾¹«áµw«×¤£¨¬ªº¤H¡A®É¶¡·¥µuªº¤H¨ã¦³«D±`ÅãµÛªºªvÀø®ÄªG¡C¥¦¥i¥H¦b°ö¨|¤¸®ð¡A¾d©T®Ú°ò¡A§§¶§¾iºë¤è±µo´§§@¥Î¡C
¦³Ãö¤é¥»ÃïÀªº§ó¦h«H®§¡A½Ð³X°Ý§Ú̪ººô¯¸https://17tengsu.tw/©Î²K¥[Line¡C